Familial hypertrophic cardiomyopathy associated with cardiac β-myosin heavy chain and troponin I mutations

Aisha Frazier, Daniel P. Judge, Steven P. Schulman, Nicole Johnson, Kathryn Holmes, Anne M. Murphy

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We report an African American family with hypertrophic cardiomyopathy in which an individual with severe disease has alterations in two sarcomeric protein genes, cardiac β-myosin heavy chain (MYH7) and troponin I (TNNI3). Each of her children has only one of these mutations. Although novel, the MYH7 mutation disrupts a conserved amino acid, and other missense substitutions at this position are known to cause disease. The TNNI3 alteration, replacing proline with serine (Pro82Ser), has been previously implicated in elderly-onset hypertrophic cardiomyopathy, although its pathogenicity is not clear. Proline in this position is conserved in all species, and its alteration to a serine is likely to result in a dramatic change in protein structure. We analyzed DNA from a panel of 100 healthy African Americans and found 3% carry the heterozygous TNNI3 missense allele that was identified in this family. Based on these findings, we propose that the TNNI3 Pro82Ser alteration is likely a disease-modifying mutation in a severely affected individual, and, furthermore, carriers of this alteration (3% of African Americans) might be at increased risk of late-onset cardiac hypertrophy.

Original languageEnglish (US)
Pages (from-to)846-850
Number of pages5
JournalPediatric Cardiology
Volume29
Issue number4
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Familial Hypertrophic Cardiomyopathy
Cardiac Myosins
Troponin I
Myosin Heavy Chains
African Americans
Hypertrophic Cardiomyopathy
Proline
Serine
Mutation
Cardiomegaly
Virulence
Proteins
Alleles
Amino Acids
DNA

Keywords

  • Cardiomyopathy
  • Myosin heavy chain
  • Polymorphic modifier
  • Troponin I

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Familial hypertrophic cardiomyopathy associated with cardiac β-myosin heavy chain and troponin I mutations. / Frazier, Aisha; Judge, Daniel P.; Schulman, Steven P.; Johnson, Nicole; Holmes, Kathryn; Murphy, Anne M.

In: Pediatric Cardiology, Vol. 29, No. 4, 07.2008, p. 846-850.

Research output: Contribution to journalArticle

Frazier, Aisha ; Judge, Daniel P. ; Schulman, Steven P. ; Johnson, Nicole ; Holmes, Kathryn ; Murphy, Anne M. / Familial hypertrophic cardiomyopathy associated with cardiac β-myosin heavy chain and troponin I mutations. In: Pediatric Cardiology. 2008 ; Vol. 29, No. 4. pp. 846-850.
@article{fe862a5f70b04d52a0192c9cad4995e7,
title = "Familial hypertrophic cardiomyopathy associated with cardiac β-myosin heavy chain and troponin I mutations",
abstract = "We report an African American family with hypertrophic cardiomyopathy in which an individual with severe disease has alterations in two sarcomeric protein genes, cardiac β-myosin heavy chain (MYH7) and troponin I (TNNI3). Each of her children has only one of these mutations. Although novel, the MYH7 mutation disrupts a conserved amino acid, and other missense substitutions at this position are known to cause disease. The TNNI3 alteration, replacing proline with serine (Pro82Ser), has been previously implicated in elderly-onset hypertrophic cardiomyopathy, although its pathogenicity is not clear. Proline in this position is conserved in all species, and its alteration to a serine is likely to result in a dramatic change in protein structure. We analyzed DNA from a panel of 100 healthy African Americans and found 3{\%} carry the heterozygous TNNI3 missense allele that was identified in this family. Based on these findings, we propose that the TNNI3 Pro82Ser alteration is likely a disease-modifying mutation in a severely affected individual, and, furthermore, carriers of this alteration (3{\%} of African Americans) might be at increased risk of late-onset cardiac hypertrophy.",
keywords = "Cardiomyopathy, Myosin heavy chain, Polymorphic modifier, Troponin I",
author = "Aisha Frazier and Judge, {Daniel P.} and Schulman, {Steven P.} and Nicole Johnson and Kathryn Holmes and Murphy, {Anne M.}",
year = "2008",
month = "7",
doi = "10.1007/s00246-007-9177-9",
language = "English (US)",
volume = "29",
pages = "846--850",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Familial hypertrophic cardiomyopathy associated with cardiac β-myosin heavy chain and troponin I mutations

AU - Frazier, Aisha

AU - Judge, Daniel P.

AU - Schulman, Steven P.

AU - Johnson, Nicole

AU - Holmes, Kathryn

AU - Murphy, Anne M.

PY - 2008/7

Y1 - 2008/7

N2 - We report an African American family with hypertrophic cardiomyopathy in which an individual with severe disease has alterations in two sarcomeric protein genes, cardiac β-myosin heavy chain (MYH7) and troponin I (TNNI3). Each of her children has only one of these mutations. Although novel, the MYH7 mutation disrupts a conserved amino acid, and other missense substitutions at this position are known to cause disease. The TNNI3 alteration, replacing proline with serine (Pro82Ser), has been previously implicated in elderly-onset hypertrophic cardiomyopathy, although its pathogenicity is not clear. Proline in this position is conserved in all species, and its alteration to a serine is likely to result in a dramatic change in protein structure. We analyzed DNA from a panel of 100 healthy African Americans and found 3% carry the heterozygous TNNI3 missense allele that was identified in this family. Based on these findings, we propose that the TNNI3 Pro82Ser alteration is likely a disease-modifying mutation in a severely affected individual, and, furthermore, carriers of this alteration (3% of African Americans) might be at increased risk of late-onset cardiac hypertrophy.

AB - We report an African American family with hypertrophic cardiomyopathy in which an individual with severe disease has alterations in two sarcomeric protein genes, cardiac β-myosin heavy chain (MYH7) and troponin I (TNNI3). Each of her children has only one of these mutations. Although novel, the MYH7 mutation disrupts a conserved amino acid, and other missense substitutions at this position are known to cause disease. The TNNI3 alteration, replacing proline with serine (Pro82Ser), has been previously implicated in elderly-onset hypertrophic cardiomyopathy, although its pathogenicity is not clear. Proline in this position is conserved in all species, and its alteration to a serine is likely to result in a dramatic change in protein structure. We analyzed DNA from a panel of 100 healthy African Americans and found 3% carry the heterozygous TNNI3 missense allele that was identified in this family. Based on these findings, we propose that the TNNI3 Pro82Ser alteration is likely a disease-modifying mutation in a severely affected individual, and, furthermore, carriers of this alteration (3% of African Americans) might be at increased risk of late-onset cardiac hypertrophy.

KW - Cardiomyopathy

KW - Myosin heavy chain

KW - Polymorphic modifier

KW - Troponin I

UR - http://www.scopus.com/inward/record.url?scp=41949113790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949113790&partnerID=8YFLogxK

U2 - 10.1007/s00246-007-9177-9

DO - 10.1007/s00246-007-9177-9

M3 - Article

C2 - 18175163

AN - SCOPUS:41949113790

VL - 29

SP - 846

EP - 850

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 4

ER -